(Q57103068)

2

0 references

Xin Chen

3

0 references

Hyunah Choo

4

0 references

Sureyya Olgen

5

0 references

Dale L Barnard

6

0 references

Robert W Sidwell

Antiviral Chemistry & Chemotherapy

7

0 references

language of work or name

English

0 references

publication date

2006

0 references

published in

0 references

volume

17

0 references

issue

5

0 references

page(s)

285-9

0 references

cites work

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Enantioselective photochemical synthesis of a simple alkene via the solid state ionic chiral auxiliary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Synthesis and anti-HIV activity of D- and L-thietanose nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Synthesis of 2',3'-dideoxy-3'-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Synthesis and anti-HIV activity of beta-D-3'-azido-2',3'-unsaturated nucleosides and beta-D-3'-azido-3'-deoxyribofuranosylnucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Synthesis of L-ribofuranosyl C-nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Identification of severe acute respiratory syndrome in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Managing SARS amidst uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Inhibition of SARS-CoV replication by siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506

Our strategies for fighting severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700506